White Angela, Burns David, Christensen Tim W
NovaSterilis Inc., Lansing, NY 14882, USA.
J Biotechnol. 2006 Jun 10;123(4):504-15. doi: 10.1016/j.jbiotec.2005.12.033. Epub 2006 Feb 21.
Gentle alternatives to existing sterilization methods are called for by rapid advances in biomedical technologies. Supercritical fluid technologies have found applications in a wide range of areas and have been explored for use in the inactivation of medical contaminants. In particular, supercritical CO(2) is appealing for sterilization due to the ease at which the supercritical state is attained, the non-reactive nature, and the ability to readily penetrate substrates. However, rapid inactivation of bacterial endospores has proven a barrier to the use of this technology for effective terminal sterilization. We report the development of a supercritical CO(2) based sterilization process capable of achieving rapid inactivation of bacterial endospores while in terminal packaging. Moreover, this process is gentle; as the morphology, ultrastructure, and protein profiles of inactivated microbes are maintained. These properties of the sterilization process suit it for possible use on a wide range of biomedical products including: materials derived from animal tissues, protein based therapies, and other sensitive medical products requiring gentle terminal sterilization.
生物医学技术的快速发展需要比现有灭菌方法更温和的替代方法。超临界流体技术已在广泛领域得到应用,并已被探索用于灭活医疗污染物。特别是,超临界二氧化碳因其易于达到超临界状态、非反应性以及易于穿透基质的能力而在灭菌方面具有吸引力。然而,事实证明,快速灭活细菌芽孢是将该技术用于有效终端灭菌的障碍。我们报告了一种基于超临界二氧化碳的灭菌工艺的开发,该工艺能够在终端包装过程中快速灭活细菌芽孢。此外,该工艺很温和;因为灭活微生物的形态、超微结构和蛋白质谱得以保持。这种灭菌工艺的这些特性使其适合用于广泛的生物医学产品,包括:来自动物组织的材料、基于蛋白质的疗法以及其他需要温和终端灭菌的敏感医疗产品。